Тhe possibilities of complex correction of antiagregational activity of the vessel wall in patients with arterial hypertension and metabolic syndrome, who suffered from the occlusion of eye vessels

The aim of this work is to investigate the possibilities of correction of a vessel wall antiaggregational, anticoagulative and fibrinolisative activity in patients with arterial hypertension and metabolic syndrome, who suffered from occlusion of eye vessels by using complex therapy including Losartan, Pioglitason and non-medic correction. It's found out that in such patients fosinopril is able to correct a vessel wall antiaggregational, anticoagulative and fibrinolisative activity after 16 weeks of therapy but doesn't fully normalize antiaggregational, anticoagulative and fibrinolisative activity. The achieved results are not stable and have the tendention to deterioration during not full non-medic correction in spite of the medical therapy.

vessel wall, arterial hypertension, metabolic syndrome, occlusion of eye vessels